TraceLink Earns Top-Tier ISO, SOC, and CyberVadis Results, Confirming Its Position as the Most Trusted Agentic Orchestration Platform for Life Sciences
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and maturity of the OPUS platform—the industry's secure, audit-ready foundation for digitalization, partner interoperability, and agentic orchestration TraceLink...
Robotware.ai Advances AI Poultry Disease Detection PoC in Malaysia with SDEC
KUALA LUMPUR, Malaysia, Dec. 17, 2025 /PRNewswire/ -- Robotware.ai , a Korea-based artificial intelligence company specializing in livestock intelligence solutions, is advancing its proof-of-concept (PoC) deployment in Malaysia in collaboration with...
smart #2 Advances Real-World Testing on All-New Electric Compact Architecture
smart's new ECA platform is being validated through rigorous testing. smart #2 will present a new vision while preserving the essential DNA of the fortwo. Progress on-track for world premiere in 2026. HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ --...
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative...
Asia's First Real-World ctDNA-MRD Study Strengthens Evidence for Cost-Effective Cancer Monitoring
A landmark study recently published in March 2025 by JCO Oncology Advances, demonstrates the potential of K-TRACKTM in monitoring treatment response and assessing recurrence risk among 623 Solid-Tumor Patients of six cancer types (lung, colorectal,...
VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model
SHANGHAI and BOSTON, April 18, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specific antibodies and antibody-drug conjugate...